SPONSOR
University of Sao Paulo General Hospital
Total Trials
11
Recruiting
11
Phases
Phase 3, Phase 4
Conditions studied: Heart FailurePhysical TherapyNeuromuscular Electrical StimulationPulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial HypertensionMenopauseTestosterone DeficiencyEstrogen DeficiencyPulmonary Thromboendarterectomy
University of Sao Paulo General Hospital is a clinical research sponsor with 11 registered studies on ClinicalTrials.gov, of which 11 are actively recruiting participants. Research covers conditions including Heart Failure, Physical Therapy, Neuromuscular Electrical Stimulation, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH).
The trial portfolio spans Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Sao Paulo General Hospital
How many clinical trials has University of Sao Paulo General Hospital sponsored?
ClinicalMetric currently tracks 11 clinical trials sponsored by University of Sao Paulo General Hospital, of which 11 are actively recruiting participants. These trials cover conditions including Heart Failure, Physical Therapy, Neuromuscular Electrical Stimulation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Sao Paulo General Hospital research focus on?
University of Sao Paulo General Hospital clinical trials span Heart Failure, Physical Therapy, Neuromuscular Electrical Stimulation, Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial Hypertension (PAH), and additional conditions. The research pipeline includes Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Sao Paulo General Hospital clinical trial?
To participate in a University of Sao Paulo General Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Sao Paulo General Hospital trials with current recruitment status updated daily.
Clinical Trials by University of Sao Paulo General Hospital
NCT06316349
Recruiting
Isolated Resistance Training and Neuromuscular Electrical Stimulation in Patients With Femoral Intra Aortic Balloon Pump.
Heart Failure
NCT06850792
Recruiting
imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNce
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
NCT06343870 Phase 3
Recruiting
Estradiol and Testosterone Subdermal Implants for Menopause Treatment (ESTIME)
Menopause
NCT07577700
Recruiting
Assessment of Pulmonary Perfusion and Hemodynamic Measurements by Electrical Impedance Tomography in Patients Undergoing Pulmonary Thromboendarterectomy.
Pulmonary Thromboendarterectomy
NCT07252804 Phase 4
Recruiting
Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases
Autoimmune Rheumatologic Disease
NCT05907239
Recruiting
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular Origin
Temporomandibular Joint Disorders
NCT06786819
Recruiting
Impact of a Technology Platform Based on Enhanced Recovery After(ERAS) Surgery on Length of Stay After Coronary Artery Bypass Grafting: Timely Project
ERAS
NCT06286891
Recruiting
Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients
Chronic Thromboembolic Pulmonary Hypertension
NCT06584773 Phase 4
Recruiting
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Disorder Related to Renal Transplantation
NCT07453017
Recruiting
Electrical Impedance Tomography for Assessment of Pulmonary Hypertension
Pulmonary Hypertension
NCT06819943
Recruiting
Effectiveness of Platform-Based Lateralization Therapy in Reducing Interface Pressure Between The Patient And The Support Surface
Respiratory Insufficiency
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology